Valacyclovir hydrochloride(CAS锛�136489-37-7) is an antiviral prescription medicine.
The global Valacyclovir Hcl API market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Valacyclovir Hcl API is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Valacyclovir Hcl API is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Valacyclovir Hcl API include Hikal, Teva, Shanghai Pharma Group Changzhou Kony Pharmaceutical Co., Ltd., Hubei Yitai Pharmaceutical, Divis Laboratories Ltd., Jubilant Generics, Hetero Drugs, Shilpa Medicare and Anhui HaiKang Pharmaceutical, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Valacyclovir Hcl API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Valacyclovir Hcl API.
The Valacyclovir Hcl API market size, estimations, and forecasts are provided in terms of output/shipments (Kg) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Valacyclovir Hcl API market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Valacyclovir Hcl API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Hikal
Teva
Shanghai Pharma Group Changzhou Kony Pharmaceutical Co., Ltd.
Hubei Yitai Pharmaceutical
Divis Laboratories Ltd.
Jubilant Generics
Hetero Drugs
Shilpa Medicare
Anhui HaiKang Pharmaceutical
Dasami Lab
Srini Pharmaceuticals
DEAFARMA
Kongo Chemical Co., Ltd.
Osaka Synthetic Chemical
Zhejiang Charioteer Pharmaceutical Co.,Ltd.
Segment by Type
Above 98 %
Above 99 %
Segment by Application
Tablets
Others
Production by Region
Europe
China
Japan
India
Israel
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by type, by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Valacyclovir Hcl API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Valacyclovir Hcl API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Valacyclovir Hcl API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Valacyclovir Hcl API Market Overview
1.1 Product Definition
1.2 Valacyclovir Hcl API Segment by Type
1.2.1 Global Valacyclovir Hcl API Market Value Growth Rate Analysis by Type 2022 VS 2029
1.2.2 Above 98 %
1.2.3 Above 99 %
1.3 Valacyclovir Hcl API Segment by Application
1.3.1 Global Valacyclovir Hcl API Market Value Growth Rate Analysis by Application: 2022 VS 2029
1.3.2 Tablets
1.3.3 Others
1.4 Global Market Growth Prospects
1.4.1 Global Valacyclovir Hcl API Production Value Estimates and Forecasts (2018-2029)
1.4.2 Global Valacyclovir Hcl API Production Capacity Estimates and Forecasts (2018-2029)
1.4.3 Global Valacyclovir Hcl API Production Estimates and Forecasts (2018-2029)
1.4.4 Global Valacyclovir Hcl API Market Average Price Estimates and Forecasts (2018-2029)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Valacyclovir Hcl API Production Market Share by Manufacturers (2018-2023)
2.2 Global Valacyclovir Hcl API Production Value Market Share by Manufacturers (2018-2023)
2.3 Global Key Players of Valacyclovir Hcl API, Industry Ranking, 2021 VS 2022 VS 2023
2.4 Global Valacyclovir Hcl API Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.5 Global Valacyclovir Hcl API Average Price by Manufacturers (2018-2023)
2.6 Global Key Manufacturers of Valacyclovir Hcl API, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Valacyclovir Hcl API, Product Offered and Application
2.8 Global Key Manufacturers of Valacyclovir Hcl API, Date of Enter into This Industry
2.9 Valacyclovir Hcl API Market Competitive Situation and Trends
2.9.1 Valacyclovir Hcl API Market Concentration Rate
2.9.2 Global 5 and 10 Largest Valacyclovir Hcl API Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Valacyclovir Hcl API Production by Region
3.1 Global Valacyclovir Hcl API Production Value Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
3.2 Global Valacyclovir Hcl API Production Value by Region (2018-2029)
3.2.1 Global Valacyclovir Hcl API Production Value Market Share by Region (2018-2023)
3.2.2 Global Forecasted Production Value of Valacyclovir Hcl API by Region (2024-2029)
3.3 Global Valacyclovir Hcl API Production Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
3.4 Global Valacyclovir Hcl API Production by Region (2018-2029)
3.4.1 Global Valacyclovir Hcl API Production Market Share by Region (2018-2023)
3.4.2 Global Forecasted Production of Valacyclovir Hcl API by Region (2024-2029)
3.5 Global Valacyclovir Hcl API Market Price Analysis by Region (2018-2023)
3.6 Global Valacyclovir Hcl API Production and Value, Year-over-Year Growth
3.6.1 Europe Valacyclovir Hcl API Production Value Estimates and Forecasts (2018-2029)
3.6.2 China Valacyclovir Hcl API Production Value Estimates and Forecasts (2018-2029)
3.6.3 Japan Valacyclovir Hcl API Production Value Estimates and Forecasts (2018-2029)
3.6.4 India Valacyclovir Hcl API Production Value Estimates and Forecasts (2018-2029)
3.6.5 Israel Valacyclovir Hcl API Production Value Estimates and Forecasts (2018-2029)
4 Valacyclovir Hcl API Consumption by Region
4.1 Global Valacyclovir Hcl API Consumption Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
4.2 Global Valacyclovir Hcl API Consumption by Region (2018-2029)
4.2.1 Global Valacyclovir Hcl API Consumption by Region (2018-2023)
4.2.2 Global Valacyclovir Hcl API Forecasted Consumption by Region (2024-2029)
4.3 North America
4.3.1 North America Valacyclovir Hcl API Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.3.2 North America Valacyclovir Hcl API Consumption by Country (2018-2029)
4.3.3 United States
4.3.4 Canada
4.4 Europe
4.4.1 Europe Valacyclovir Hcl API Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.4.2 Europe Valacyclovir Hcl API Consumption by Country (2018-2029)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Valacyclovir Hcl API Consumption Growth Rate by Region: 2018 VS 2022 VS 2029
4.5.2 Asia Pacific Valacyclovir Hcl API Consumption by Region (2018-2029)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Valacyclovir Hcl API Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.6.2 Latin America, Middle East & Africa Valacyclovir Hcl API Consumption by Country (2018-2029)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
4.6.6 GCC Countries
5 Segment by Type
5.1 Global Valacyclovir Hcl API Production by Type (2018-2029)
5.1.1 Global Valacyclovir Hcl API Production by Type (2018-2023)
5.1.2 Global Valacyclovir Hcl API Production by Type (2024-2029)
5.1.3 Global Valacyclovir Hcl API Production Market Share by Type (2018-2029)
5.2 Global Valacyclovir Hcl API Production Value by Type (2018-2029)
5.2.1 Global Valacyclovir Hcl API Production Value by Type (2018-2023)
5.2.2 Global Valacyclovir Hcl API Production Value by Type (2024-2029)
5.2.3 Global Valacyclovir Hcl API Production Value Market Share by Type (2018-2029)
5.3 Global Valacyclovir Hcl API Price by Type (2018-2029)
6 Segment by Application
6.1 Global Valacyclovir Hcl API Production by Application (2018-2029)
6.1.1 Global Valacyclovir Hcl API Production by Application (2018-2023)
6.1.2 Global Valacyclovir Hcl API Production by Application (2024-2029)
6.1.3 Global Valacyclovir Hcl API Production Market Share by Application (2018-2029)
6.2 Global Valacyclovir Hcl API Production Value by Application (2018-2029)
6.2.1 Global Valacyclovir Hcl API Production Value by Application (2018-2023)
6.2.2 Global Valacyclovir Hcl API Production Value by Application (2024-2029)
6.2.3 Global Valacyclovir Hcl API Production Value Market Share by Application (2018-2029)
6.3 Global Valacyclovir Hcl API Price by Application (2018-2029)
7 Key Companies Profiled
7.1 Hikal
7.1.1 Hikal Valacyclovir Hcl API Corporation Information
7.1.2 Hikal Valacyclovir Hcl API Product Portfolio
7.1.3 Hikal Valacyclovir Hcl API Production, Value, Price and Gross Margin (2018-2023)
7.1.4 Hikal Main Business and Markets Served
7.1.5 Hikal Recent Developments/Updates
7.2 Teva
7.2.1 Teva Valacyclovir Hcl API Corporation Information
7.2.2 Teva Valacyclovir Hcl API Product Portfolio
7.2.3 Teva Valacyclovir Hcl API Production, Value, Price and Gross Margin (2018-2023)
7.2.4 Teva Main Business and Markets Served
7.2.5 Teva Recent Developments/Updates
7.3 Shanghai Pharma Group Changzhou Kony Pharmaceutical Co., Ltd.
7.3.1 Shanghai Pharma Group Changzhou Kony Pharmaceutical Co., Ltd. Valacyclovir Hcl API Corporation Information
7.3.2 Shanghai Pharma Group Changzhou Kony Pharmaceutical Co., Ltd. Valacyclovir Hcl API Product Portfolio
7.3.3 Shanghai Pharma Group Changzhou Kony Pharmaceutical Co., Ltd. Valacyclovir Hcl API Production, Value, Price and Gross Margin (2018-2023)
7.3.4 Shanghai Pharma Group Changzhou Kony Pharmaceutical Co., Ltd. Main Business and Markets Served
7.3.5 Shanghai Pharma Group Changzhou Kony Pharmaceutical Co., Ltd. Recent Developments/Updates
7.4 Hubei Yitai Pharmaceutical
7.4.1 Hubei Yitai Pharmaceutical Valacyclovir Hcl API Corporation Information
7.4.2 Hubei Yitai Pharmaceutical Valacyclovir Hcl API Product Portfolio
7.4.3 Hubei Yitai Pharmaceutical Valacyclovir Hcl API Production, Value, Price and Gross Margin (2018-2023)
7.4.4 Hubei Yitai Pharmaceutical Main Business and Markets Served
7.4.5 Hubei Yitai Pharmaceutical Recent Developments/Updates
7.5 Divis Laboratories Ltd.
7.5.1 Divis Laboratories Ltd. Valacyclovir Hcl API Corporation Information
7.5.2 Divis Laboratories Ltd. Valacyclovir Hcl API Product Portfolio
7.5.3 Divis Laboratories Ltd. Valacyclovir Hcl API Production, Value, Price and Gross Margin (2018-2023)
7.5.4 Divis Laboratories Ltd. Main Business and Markets Served
7.5.5 Divis Laboratories Ltd. Recent Developments/Updates
7.6 Jubilant Generics
7.6.1 Jubilant Generics Valacyclovir Hcl API Corporation Information
7.6.2 Jubilant Generics Valacyclovir Hcl API Product Portfolio
7.6.3 Jubilant Generics Valacyclovir Hcl API Production, Value, Price and Gross Margin (2018-2023)
7.6.4 Jubilant Generics Main Business and Markets Served
7.6.5 Jubilant Generics Recent Developments/Updates
7.7 Hetero Drugs
7.7.1 Hetero Drugs Valacyclovir Hcl API Corporation Information
7.7.2 Hetero Drugs Valacyclovir Hcl API Product Portfolio
7.7.3 Hetero Drugs Valacyclovir Hcl API Production, Value, Price and Gross Margin (2018-2023)
7.7.4 Hetero Drugs Main Business and Markets Served
7.7.5 Hetero Drugs Recent Developments/Updates
7.8 Shilpa Medicare
7.8.1 Shilpa Medicare Valacyclovir Hcl API Corporation Information
7.8.2 Shilpa Medicare Valacyclovir Hcl API Product Portfolio
7.8.3 Shilpa Medicare Valacyclovir Hcl API Production, Value, Price and Gross Margin (2018-2023)
7.8.4 Shilpa Medicare Main Business and Markets Served
7.7.5 Shilpa Medicare Recent Developments/Updates
7.9 Anhui HaiKang Pharmaceutical
7.9.1 Anhui HaiKang Pharmaceutical Valacyclovir Hcl API Corporation Information
7.9.2 Anhui HaiKang Pharmaceutical Valacyclovir Hcl API Product Portfolio
7.9.3 Anhui HaiKang Pharmaceutical Valacyclovir Hcl API Production, Value, Price and Gross Margin (2018-2023)
7.9.4 Anhui HaiKang Pharmaceutical Main Business and Markets Served
7.9.5 Anhui HaiKang Pharmaceutical Recent Developments/Updates
7.10 Dasami Lab
7.10.1 Dasami Lab Valacyclovir Hcl API Corporation Information
7.10.2 Dasami Lab Valacyclovir Hcl API Product Portfolio
7.10.3 Dasami Lab Valacyclovir Hcl API Production, Value, Price and Gross Margin (2018-2023)
7.10.4 Dasami Lab Main Business and Markets Served
7.10.5 Dasami Lab Recent Developments/Updates
7.11 Srini Pharmaceuticals
7.11.1 Srini Pharmaceuticals Valacyclovir Hcl API Corporation Information
7.11.2 Srini Pharmaceuticals Valacyclovir Hcl API Product Portfolio
7.11.3 Srini Pharmaceuticals Valacyclovir Hcl API Production, Value, Price and Gross Margin (2018-2023)
7.11.4 Srini Pharmaceuticals Main Business and Markets Served
7.11.5 Srini Pharmaceuticals Recent Developments/Updates
7.12 DEAFARMA
7.12.1 DEAFARMA Valacyclovir Hcl API Corporation Information
7.12.2 DEAFARMA Valacyclovir Hcl API Product Portfolio
7.12.3 DEAFARMA Valacyclovir Hcl API Production, Value, Price and Gross Margin (2018-2023)
7.12.4 DEAFARMA Main Business and Markets Served
7.12.5 DEAFARMA Recent Developments/Updates
7.13 Kongo Chemical Co., Ltd.
7.13.1 Kongo Chemical Co., Ltd. Valacyclovir Hcl API Corporation Information
7.13.2 Kongo Chemical Co., Ltd. Valacyclovir Hcl API Product Portfolio
7.13.3 Kongo Chemical Co., Ltd. Valacyclovir Hcl API Production, Value, Price and Gross Margin (2018-2023)
7.13.4 Kongo Chemical Co., Ltd. Main Business and Markets Served
7.13.5 Kongo Chemical Co., Ltd. Recent Developments/Updates
7.14 Osaka Synthetic Chemical
7.14.1 Osaka Synthetic Chemical Valacyclovir Hcl API Corporation Information
7.14.2 Osaka Synthetic Chemical Valacyclovir Hcl API Product Portfolio
7.14.3 Osaka Synthetic Chemical Valacyclovir Hcl API Production, Value, Price and Gross Margin (2018-2023)
7.14.4 Osaka Synthetic Chemical Main Business and Markets Served
7.14.5 Osaka Synthetic Chemical Recent Developments/Updates
7.15 Zhejiang Charioteer Pharmaceutical Co.,Ltd.
7.15.1 Zhejiang Charioteer Pharmaceutical Co.,Ltd. Valacyclovir Hcl API Corporation Information
7.15.2 Zhejiang Charioteer Pharmaceutical Co.,Ltd. Valacyclovir Hcl API Product Portfolio
7.15.3 Zhejiang Charioteer Pharmaceutical Co.,Ltd. Valacyclovir Hcl API Production, Value, Price and Gross Margin (2018-2023)
7.15.4 Zhejiang Charioteer Pharmaceutical Co.,Ltd. Main Business and Markets Served
7.15.5 Zhejiang Charioteer Pharmaceutical Co.,Ltd. Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Valacyclovir Hcl API Industry Chain Analysis
8.2 Valacyclovir Hcl API Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Valacyclovir Hcl API Production Mode & Process
8.4 Valacyclovir Hcl API Sales and Marketing
8.4.1 Valacyclovir Hcl API Sales Channels
8.4.2 Valacyclovir Hcl API Distributors
8.5 Valacyclovir Hcl API Customers
9 Valacyclovir Hcl API Market Dynamics
9.1 Valacyclovir Hcl API Industry Trends
9.2 Valacyclovir Hcl API Market Drivers
9.3 Valacyclovir Hcl API Market Challenges
9.4 Valacyclovir Hcl API Market Restraints
10 Research Finding and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
Hikal
Teva
Shanghai Pharma Group Changzhou Kony Pharmaceutical Co., Ltd.
Hubei Yitai Pharmaceutical
Divis Laboratories Ltd.
Jubilant Generics
Hetero Drugs
Shilpa Medicare
Anhui HaiKang Pharmaceutical
Dasami Lab
Srini Pharmaceuticals
DEAFARMA
Kongo Chemical Co., Ltd.
Osaka Synthetic Chemical
Zhejiang Charioteer Pharmaceutical Co.,Ltd.
听
听
*If Applicable.
